Brief report: HIV-1 transmissions during asymptomatic infection: Exploring the impact of changes in HIV-1 viral load due to coinfections

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 5, 2015, Pages 594-598

  Baggaley, Rebecca F ^a   Hollingsworth, T Déirdre ^b,c,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

coinfections; helminth; herpes; HIV; malaria; transmission; tuberculosis; viral load

Indexed keywords

ARTICLE; ASYMPTOMATIC INFECTION; FILARIASIS; GONORRHEA; HELMINTHIASIS; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALARIA; MIXED INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; SCHISTOSOMIASIS; SECONDARY INFECTION; SURVIVAL; SYPHILIS; TUBERCULOSIS; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION; ADULT; AFRICA SOUTH OF THE SAHARA; BACTERIAL INFECTIONS; COINFECTION; COMPLICATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; PARASITIC DISEASES; TRANSMISSION;

ADULT; AFRICA SOUTH OF THE SAHARA; ASYMPTOMATIC INFECTIONS; BACTERIAL INFECTIONS; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PARASITIC DISEASES; VIRAL LOAD;

EID: 84925235420     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000511     Document Type: Article

References (27)

1. Abu-Raddad LJ, Barnabas RV, Janes H, et al. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS. 2013;27:2494-2496.
2. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929.
3. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses. 2001;17:901-910.
4. Barnabas RV, Webb EL, Weiss HA, et al. The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS. 2011;25:1559-1573.
5. Walson JL, John-Stewart G. Treatment of helminth co-infection in individuals with HIV-1: a systematic review of the literature. PLoS Negl Trop Dis. 2007;1:e102.
6. Cuadros DF, Garcia-Ramos G. Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance. Theor Biol Med Model. 2012;9:9.
7. Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009;23:461-469.
8. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356:790-799.
9. Fraser C, Hollingsworth TD, Chapman R, et al. Variation in HIV-1 setpoint viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A. 2007;104:17441-17446.
10. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427-439.
11. Lingappa JR, Baeten JM, Wald A, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet. 2010;375:824-833.
12. Reynolds SJ, Makumbi F, Newell K, et al. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial. Lancet Infect Dis. 2012;12:441-448.
13. McMahon MA, Siliciano JD, Lai J, et al. The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem. 2008;283:31289-31293.
14. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
15. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis. 2008;198:687-693.
16. Williams BG, Korenromp EL, Gouws E, et al. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis. 2006;194:1450-1458.
17. Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis. 2010;10:455-463.
18. Mugwanya K, Baeten JM, Mugo NR, et al. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial. J Infect Dis. 2011;204:1912-1917.
19. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
20. Aghaizu A, Brown AE, Nardone A, et al. HIV in the United Kingdom 2013 Report: Data to End 2012. London, United Kingdom: Public Health England; 2013.
21. de Wolf F, Spijkerman I, Schellekens PT, et al. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS. 1997;11:1799-1806.
22. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis. 2006; 42:1333-1339.
23. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis. 2008;197:707-713.
24. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3:77ra29.
25. Cuadros DF, Crowley PH, Augustine B, et al. Effect of variable transmission rate on the dynamics of HIV in sub-Saharan Africa. BMC Infect Dis. 2011;11:216.
26. Anderson RM, Truscott JE, Pullan RL, et al. How effective is schoolbased deworming for the community-wide control of soil-transmitted helminths? PLoS Negl Trop Dis. 2013;7:e2027.
27. Williams BG. Determinants of sexual transmission of HIV: implications for control. 2011. Available at: http://arxiv.org/ftp/arxiv/papers/1108/ 1108.4715.pdf. Accessed October 15, 2012.